COL1A1 and dermatofibrosarcoma protuberans: Imatinib has also shown antitumor effect in preclinical models of DFSP and giant-cell fibroblastoma, which are rare, recurrent, and infiltrative tumors of the dermis classically characterized by a COL1A1/PDGFB translocation [62,63].